Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.49
Delayed Data
As of 3:59pm ET
 -0.04 / -2.61%
Today’s Change
1.46
Today|||52-Week Range
28.40
-71.31%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close1.53
Today’s open1.52
Day’s range1.46 - 1.53
Volume360,899
Average volume (3 months)287,190
Market cap$15.4M
Dividend yield--
Data as of 3:59pm ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)-62.63%
Earnings growth (this year)--
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-95.45%
P/E ratioNM
Price/Sales184.93
Price/Book2.28

Competitors

 Today’s
change
Today’s
% change
EVARLombard Medical Inc-0.05-9.26%
EYEGEyeGate Pharmaceutic...+0.02+1.45%
SBOTStellar Biotechnolog...0.000.00%
IMRNImmuron Ltd+0.08+1.28%
Data as of 4:00pm ET, 07/26/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)-$1.09
Annual revenue (last year)$145.0K
Annual profit (last year)-$55.5M
Net profit margin-38,291.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts